X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SHASUN PHARMA with Natco Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs NATCO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA NATCO PHARMA SHASUN PHARMA/
NATCO PHARMA
 
P/E (TTM) x 123.9 30.4 408.1% View Chart
P/BV x 8.5 23.0 37.1% View Chart
Dividend Yield % 0.2 0.5 46.9%  

Financials

 SHASUN PHARMA   NATCO PHARMA
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
NATCO PHARMA
Mar-14
SHASUN PHARMA/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs94877 10.7%   
Low Rs46424 10.8%   
Sales per share (Unadj.) Rs214.2223.4 95.9%  
Earnings per share (Unadj.) Rs5.331.1 17.2%  
Cash flow per share (Unadj.) Rs15.840.3 39.3%  
Dividends per share (Unadj.) Rs1.005.00 20.0%  
Dividend yield (eoy) %1.40.8 186.1%  
Book value per share (Unadj.) Rs53.3219.5 24.3%  
Shares outstanding (eoy) m56.6233.07 171.2%   
Bonus/Rights/Conversions -PA-  
Price / Sales ratio x0.32.9 11.2%   
Avg P/E ratio x13.120.9 62.6%  
P/CF ratio (eoy) x4.416.1 27.4%  
Price / Book Value ratio x1.33.0 44.2%  
Dividend payout %18.716.1 116.4%   
Avg Mkt Cap Rs m3,95821,504 18.4%   
No. of employees `000NANA-   
Total wages/salary Rs m2,1641,128 191.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m12,1277,389 164.1%  
Other income Rs m229167 137.3%   
Total revenues Rs m12,3567,556 163.5%   
Gross profit Rs m1,0091,793 56.3%  
Depreciation Rs m594304 195.0%   
Interest Rs m415366 113.4%   
Profit before tax Rs m2301,290 17.8%   
Minority Interest Rs m046 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-73309 -23.6%   
Profit after tax Rs m3021,027 29.4%  
Gross profit margin %8.324.3 34.3%  
Effective tax rate %-31.723.9 -132.3%   
Net profit margin %2.513.9 17.9%  
BALANCE SHEET DATA
Current assets Rs m6,8843,681 187.0%   
Current liabilities Rs m8,4563,123 270.8%   
Net working cap to sales %-13.07.6 -171.4%  
Current ratio x0.81.2 69.1%  
Inventory Days Days6289 68.9%  
Debtors Days Days10859 183.3%  
Net fixed assets Rs m4,9707,685 64.7%   
Share capital Rs m113331 34.3%   
"Free" reserves Rs m2,8756,670 43.1%   
Net worth Rs m3,0207,259 41.6%   
Long term debt Rs m1,817955 190.3%   
Total assets Rs m13,34711,957 111.6%  
Interest coverage x1.64.5 34.4%   
Debt to equity ratio x0.60.1 457.4%  
Sales to assets ratio x0.90.6 147.0%   
Return on assets %5.411.7 46.1%  
Return on equity %10.014.2 70.7%  
Return on capital %13.320.7 64.3%  
Exports to sales %46.439.4 117.8%   
Imports to sales %14.25.7 249.9%   
Exports (fob) Rs m5,6222,908 193.3%   
Imports (cif) Rs m1,728421 410.2%   
Fx inflow Rs m5,8433,445 169.6%   
Fx outflow Rs m2,173703 309.2%   
Net fx Rs m3,6692,743 133.8%   
CASH FLOW
From Operations Rs m3981,440 27.6%  
From Investments Rs m-1,635-1,089 150.1%  
From Financial Activity Rs m1,309-353 -371.0%  
Net Cashflow Rs m71-1 -4,778.5%  

Share Holding

Indian Promoters % 39.2 52.0 75.3%  
Foreign collaborators % 0.0 1.5 -  
Indian inst/Mut Fund % 3.6 7.8 45.9%  
FIIs % 17.6 16.6 105.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 26.0 152.3%  
Shareholders   20,750 25,395 81.7%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   DISHMAN PHARMA  ELDER PHARMA  SUVEN LIFE  PANACEA BIOTECH  WOCKHARDT LTD.  

Compare SHASUN PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades on a Positive Note; Apollo Micro Systems IPO Lists at 74% Premium(11:30 am)

Stock markets in India are presently trading marginally higher. Sectoral indices are trading on a mixed note with stocks in the energy sector and IT sector witnessing maximum buying interest.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 5-YR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS